[{"NetIncomeLoss_1_Q3_USD":-23075000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":448617000.0,"Liabilities_0_Q3_USD":128992000.0,"HeldToMaturitySecurities_0_Q3_USD":63705000.0,"MarketableSecuritiesCurrent_0_Q3_USD":51021000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":26061000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9136000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":29014000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":29061000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-17000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":19819000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":5094000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-7386000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2736000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1236484.0,"CurrentFederalTaxExpenseBenefit_1_Q3_USD":126000.0,"AssetsCurrent_0_Q3_USD":201316000.0,"DueToRelatedPartiesNoncurrent_0_Q3_USD":80494000.0,"CurrentStateAndLocalTaxExpenseBenefit_3_Q3_USD":143000.0,"CurrentStateAndLocalTaxExpenseBenefit_1_Q3_USD":131000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":18657000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_3_Q3_USD":-2000.0,"IncomeTaxesPaidNet_3_Q3_USD":235000.0,"CommonStockSharesIssued_0_Q3_shares":29074536.0,"Assets_0_Q3_USD":213493000.0,"DebtAndEquitySecuritiesUnrealizedGainLoss_3_Q3_USD":30000.0,"ShareBasedCompensation_3_Q3_USD":6327000.0,"CurrentFederalTaxExpenseBenefit_3_Q3_USD":164000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":4229000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":139179000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.013,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-14187000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":48234000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":17538000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":3767000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":5707000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-3876000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-4794000.0,"AccountsReceivableNetCurrent_0_Q3_USD":538000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.86,"IncomeTaxExpenseBenefit_1_Q3_USD":177000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":305000.0,"CommonStockValue_0_Q3_USD":2938000.0,"OtherAssetsNoncurrent_0_Q3_USD":1081000.0,"Revenues_3_Q3_USD":20927000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":830000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-4243000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-4782000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":751000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_3_Q3_USD":-8000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_1_Q3_USD":-24000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":42831000.0,"DeferredRevenueNoncurrent_0_Q3_USD":331000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":190200000.0,"OtherAssetsCurrent_0_Q3_USD":1876000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1587000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":206000.0,"Revenues_1_Q3_USD":8570000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":291000.0,"CommonStockParOrStatedValuePerShare_0_Q3_EUR":0.09,"InterestReceivableCurrent_0_Q3_USD":187000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-634000.0,"CommonStockSharesOutstanding_0_Q3_shares":29074536.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":49359000.0,"DeferredFederalIncomeTaxExpenseBenefit_3_Q3_USD":6000.0,"DeferredFederalIncomeTaxExpenseBenefit_1_Q3_USD":-56000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-57244000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-22898000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2844000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":3508000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":4414000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-55565000.0,"LiabilitiesCurrent_0_Q3_USD":45431000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-58433000.0,"DeferredRevenueCurrent_0_Q3_USD":699000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":139380000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":9010000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":915000.0,"SeveranceCosts1_3_Q3_USD":100000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":16000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":0.0,"OperatingLeasePayments_3_Q3_USD":1201000.0,"OperatingLeasePayments_1_Q3_USD":412000.0,"HeldToMaturitySecuritiesFairValue_0_Q3_USD":63749000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":5000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3792000.0,"NetIncomeLoss_3_Q3_USD":-57549000.0,"AccountsPayableCurrent_0_Q3_USD":4720000.0,"LeaseCost_1_Q3_USD":504000.0,"LeaseCost_3_Q3_USD":1485000.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":257000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":11.72,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2935000.0,"CommonStockSharesAuthorized_0_Q3_shares":45000000.0,"OperatingIncomeLoss_3_Q3_USD":-53368000.0,"OperatingIncomeLoss_1_Q3_USD":-18104000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-2000.0,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":-80000.0,"OperatingLeaseCost_3_Q3_USD":1203000.0,"OperatingLeaseCost_1_Q3_USD":411000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":213493000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2905000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":6327000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2844000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1536000.0,"OperatingExpenses_3_Q3_USD":74295000.0,"OperatingExpenses_1_Q3_USD":26674000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.86,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.64,"ProfitLoss_3_Q3_USD":-57549000.0,"StockholdersEquity_0_Q3_USD":84501000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":858000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":2784000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q3_USD":1568000.0,"VariableLeaseCost_3_Q3_USD":282000.0,"VariableLeaseCost_1_Q3_USD":93000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-372148000.0,"CurrentIncomeTaxExpenseBenefit_3_Q3_USD":307000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-18661000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-54041000.0,"Ticker":"MRUS","CIK":"1651311","name":"MERUS N.V.","OfficialName":"Merus N.V. Common Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1055622823.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]